Table 1.
Baseline characteristics.
Factor | All PE N = 69 |
High-risk PE N = 10 |
Intermediate-risk PE N = 59 |
---|---|---|---|
Age, mean ± SD | 59.20 ± 15.38 | 68.2 ± 8.95 | 57.68 ± 15.77 |
Female, sex | 39 (57%) | 8 (80%) | 31 (53%) |
PE type | |||
High-risk | 10 (14%) | – | – |
Intermediate-risk | 59 (86%) | – | – |
PE Laterality | |||
Unilateral | 3 (4%) | 0 (0%) | 3 (5%) |
Bilateral | 66 (96%) | 10 (100%) | 56 (95%) |
Hypercoagulable state | 4 (6%) | 0 (0%) | 4 (7%) |
Recent surgery | 16 (23%) | 4 (40%) | 12 (20%) |
Cancer | 10 (14%) | 3 (30%) | 7 (12%) |
Hormonal therapy | 5 (7%) | 0 (0%) | 5 (8%) |
Recent travel | 12 (17%) | 1 (10%) | 11 (19%) |
Recent trauma | 1 (1%) | 0 (0%) | 1 (2%) |
Concurrent DVT | 36 (52%) | 5 (50%) | 31 (53%) |
History of DVT | 11 (16%) | 0 (0%) | 11 (19%) |
History of PE | 10 (14%) | 1 (10%) | 9 (15%) |
Coronary artery disease | 8 (12%) | 1 (10%) | 7 (12%) |
Heart failure history | 3 (4%) | 1 (10%) | 2 (3%) |
Pulmonary hypertension history | 2 (3%) | 0 (0%) | 2 (3%) |
Pulmonary disease history | 7 (10%) | 1 (10%) | 6 (10%) |
PE: pulmonary embolism; DVT: deep vein thrombolysis.